Delaware Research Group, LLC

Delaware, Ohio 43015

0 studies enrolling now · 2 studies all time

What they study most

Cardiovascular Disease, High Cardiovascular Risk, Obesity, Overweight, Type 2 Diabetes

Studies at this site

• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• The Evaluation of Bococizumab (PF-04950615; RN316) in Reducing the Occurrence of Major Cardiovascular Events in High Risk Subjects — Stopped early